OTCMKTS:GOVX - Geovax Labs Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.45 -0.20 (-12.12 %) (As of 05/24/2019 04:00 PM ET)Previous Close$1.45Today's Range$1.45 - $1.6552-Week Range$0.0075 - $0.05Volume23,321 shsAverage Volume595,780 shsMarket Capitalization$403.16 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U.S. Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; U.S. Department of Defense; Geneva Foundation; Enesi Pharma; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia. Receive GOVX News and Ratings via Email Sign-up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GOVX Previous SymbolNASDAQ:GOVX CUSIPN/A CIK832489 Webhttp://www.geovax.com/ Phone678-384-7220Debt Debt-to-Equity RatioN/A Current Ratio0.38 Quick Ratio0.38Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$960,000.00 Price / Sales419.96 Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-145.00Profitability EPS (Most Recent Fiscal Year)($0.02) Net Income$-2,560,000.00 Net Margins-266.11% Return on EquityN/A Return on Assets-415.92%Miscellaneous Employees8 Outstanding Shares278,040,000Market Cap$403.16 million Next Earnings DateN/A OptionableNot Optionable Geovax Labs (OTCMKTS:GOVX) Frequently Asked Questions What is Geovax Labs' stock symbol? Geovax Labs trades on the OTCMKTS under the ticker symbol "GOVX." How were Geovax Labs' earnings last quarter? Geovax Labs Inc (OTCMKTS:GOVX) announced its quarterly earnings results on Thursday, May, 3rd. The biotechnology company reported ($0.01) earnings per share for the quarter. The biotechnology company had revenue of $0.22 million for the quarter. View Geovax Labs' Earnings History. Has Geovax Labs been receiving favorable news coverage? News articles about GOVX stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Geovax Labs earned a daily sentiment score of 1.6 on InfoTrie's scale. They also assigned news articles about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. Who are some of Geovax Labs' key competitors? Some companies that are related to Geovax Labs include Intrexon (XON), Sorrento Therapeutics (SRNE), Eloxx Pharmaceuticals (ELOX), STARPHARMA HOLD/S (SPHRY), Pieris Pharmaceuticals (PIRS), Anavex Life Sciences (AVXL), Luna Innovations (LUNA), Senomyx (SNMX), BIOQUAL (BIOQ), HedgePath Pharmaceuticals (HPPI), Bioanalytical Systems (BASI), Cleveland BioLabs (CBLI), Vitality Biopharma (VBIO), Tenax Therapeutics (TENX) and US Stem Cell (USRM). What other stocks do shareholders of Geovax Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other Geovax Labs investors own include Ekso Bionics (EKSO), Mondi (MNDI), Akebia Therapeutics (AKBA), Anavex Life Sciences (AVXL), BioDelivery Sciences International (BDSI), Novavax (NVAX), Ophthotech (OPHT), Synergy Pharmaceuticals (SGYP), Vascular Biogenics (VBLT) and Castle Brands (ROX). Who are Geovax Labs' key executives? Geovax Labs' management team includes the folowing people: Mr. David Alan Dodd, Chairman, CEO & Pres (Age 69)Dr. Harriet Latham Robinson, Co-Founder, Chief Scientific Officer Emeritus & Director (Age 81)Mr. Mark W. Reynolds CPA, CPA, CFO & Corp. Sec. (Age 57)Dr. Farshad Guirakhoo, Chief Scientific Officer (Age 66)Mr. Donald G. Hildebrand, Founder, Chairman Emeritus & Consultant (Age 78) How do I buy shares of Geovax Labs? Shares of GOVX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Geovax Labs' stock price today? One share of GOVX stock can currently be purchased for approximately $1.45. How big of a company is Geovax Labs? Geovax Labs has a market capitalization of $403.16 million and generates $960,000.00 in revenue each year. The biotechnology company earns $-2,560,000.00 in net income (profit) each year or ($0.02) on an earnings per share basis. Geovax Labs employs 8 workers across the globe. What is Geovax Labs' official website? The official website for Geovax Labs is http://www.geovax.com/. How can I contact Geovax Labs? Geovax Labs' mailing address is 1900 LAKE PARK DRIVE SUITE 380, SMYRNA GA, 30080. The biotechnology company can be reached via phone at 678-384-7220 or via email at [email protected] MarketBeat Community Rating for Geovax Labs (OTCMKTS GOVX)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 61 (Vote Outperform)Underperform Votes: 43 (Vote Underperform)Total Votes: 104MarketBeat's community ratings are surveys of what our community members think about Geovax Labs and other stocks. Vote "Outperform" if you believe GOVX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GOVX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/25/2019 by MarketBeat.com StaffFeatured Article: What is a good dividend yield? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.